US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Current health news covers major investments by Merck Animal Health and Gilead Sciences in the U.S., regulatory decisions ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

Eli Lilly's stock price rise of 9% YTD might ... The most concerning of the potential drags on LLY were its recent legal issues. The company had just sued the government's Health Resources and ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against ... "Their use remains appropriate and legal when tailored to individual patient needs and prescribed by a licensed medical provider ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

Eli Lilly (NYSE:LLY ... is also over. Earlier in April, Lilly took legal action against two compounding pharmacies seeking to stop them from manufacturing and marketing compounded tirzepatide.

President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...